Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling

Broad-spectrum antiviral agents that are effective against many viruses are difficult to develop, as the key molecules, as well as the biochemical pathways by which they cause infection, differ largely from one virus to another. This was more strongly highlighted by the COVID-19 pandemic, which foun...

Descripción completa

Detalles Bibliográficos
Autores principales: Zagaliotis, Panagiotis, Petrou, Anthi, Mystridis, George A., Geronikaki, Athina, Vizirianakis, Ioannis S., Walsh, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325261/
https://www.ncbi.nlm.nih.gov/pubmed/35887353
http://dx.doi.org/10.3390/ijms23148006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325261/
https://www.ncbi.nlm.nih.gov/pubmed/35887353
http://dx.doi.org/10.3390/ijms23148006

Ejemplares similares